The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro , In Vivo , and In Silico Studies of Macromolecular Targets
Microbiology Spectrum · 2023
DOI: 10.1128/spectrum.01393-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Vinícius Roquini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Schistosomicides, Schistosomiasis mansoni, Schistosomiasis, Nitrofurans. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
The increasing recognition of the burden imposed by helminthiasis, associated with the limited therapeutic arsenal, has led to initiatives and strategies to research and develop new drugs for the treatment of schistosomiasis. One of these strategies is drug repurposing, which considers low-risk compounds with potentially reduced costs and shorter time for development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil.
- Laboratory of Immunopathology of Schistosomiasis (LIM-06), Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo, Brazil.
- Laboratory of Helminthology, Institute of Tropical Medicine, University of São Paulo, São Paulo, São Paulo, Brazil.
- Biological Chemistry Post-Graduate Course, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.
- Institute of Physics, University of São Paulo, São Paulo, São Paulo, Brazil.
- Chemico-Pharmaceutical Research Group, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.
ORCID-Profile: Josué de Moraes
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Roquini, V., Mengarda, A. C., Cajas, R. A., Martins-da-Silva, M. F., Godoy-Silva, J., Santos, G. A., Espírito-Santo, M. C. C., Pavani, T. F. A., Melo, V. A., Salvadori, M. C., Teixeira, F. S., Rando, D. G. G., & de Moraes, J. (2023). The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro , In Vivo , and In Silico Studies of Macromolecular Targets. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01393-23
Vancouver
Roquini V, Mengarda AC, Cajas RA, Martins-da-Silva MF, Godoy-Silva J, Santos GA, et al. The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro , In Vivo , and In Silico Studies of Macromolecular Targets. Microbiology Spectrum. 2023. doi:10.1128/spectrum.01393-23
BibTeX
@article{Roquini2023,
author = {Roquini, Vinícius and Mengarda, Ana C and Cajas, Rayssa A and Martins-da-Silva, Milene F and Godoy-Silva, Julia and Santos, Gustavo A and Espírito-Santo, Maria Cristina C and Pavani, Thais F A and Melo, Vanusa A and Salvadori, Maria C and Teixeira, Fernanda S and Rando, Daniela G G and de Moraes, Josué},
title = {The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro , In Vivo , and In Silico Studies of Macromolecular Targets},
journal = {Microbiology Spectrum},
year = {2023},
doi = {10.1128/spectrum.01393-23}
}
EUVIMED